Unichem Laboratories is currently buying and selling at Rs. 186.80, up through zero.Forty five points or 0.24% from its previous last of Rs. 186.35 on the BSE.

The scrip opened at Rs. 186.20 and has touched a excessive and low of Rs. 189.95 and Rs. 185.50 respectively. So some distance 3519 stocks had been traded at the counter.

The BSE organization ‘B’ stock of face cost Rs. 2 has touched a 52 week excessive of Rs. 288.Forty on 08-May-2018 and a 52 week low of Rs. 182.00 on 11-Oct-2018.

Last one week excessive and coffee of the scrip stood at Rs. 192.Ninety five and Rs. 185.50 respectively. The current marketplace cap of the organization is Rs. 1314.76 crore.

The promoters protecting in the organisation stood at 50.Sixty four%, even as Institutions and Non-Institutions held nine.Forty one% and 39.Ninety five% respectively.

Unichem Laboratories has obtained tentative ANDA approval from america Food and Drug Administration (USFDA) for Unichem’s Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets USP, 5 mg/120 mg (OTC) to market a typical version of Johnson and Johnson Consumer Inc’s Zyrtec-D 12 Hour (Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride, 5mg/a hundred and twenty mg) Extended Tablets.

The product could be commercialized from Unichem’s Goa Plant on receipt of very last approval.